Abstract
Spherical nanoparticles based on the biocompatible and biodegradable poly(d,l-lactide-co-glycolide) copolymer (90 : 10) loaded with oxaliplatin were produced by nanoprecipitation. Effect of the oxaliplatin loading on structure, size and morphology of the copolymer particles is considered. The nanoformulation of oxaliplatin demonstrates enhanced cytotoxicity and selectivity in vitro against several cancer cells compared with the free drug.
References
1.
Oberoi H.S., Nukolova N.V., Kabanov A.V., Bronich T.K.
Advanced Drug Delivery Reviews,
2013
2.
Dilruba S., Kalayda G.V.
Cancer Chemotherapy and Pharmacology,
2016
3.
Arantseva D.A., Vodovozova E.L.
Russian Journal of Bioorganic Chemistry,
2018
4.
Kadina Y.A., Razuvaeva E.V., Streltsov D.R., Sedush N.G., Shtykova E.V., Kulebyakina A.I., Puchkov A.A., Volkov D.S., Nazarov A.A., Chvalun S.N.
Molecules,
2021
5.
Narmani A., Kamali M., Amini B., Salimi A., Panahi Y.
Process Biochemistry,
2018
6.
Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles
Tummala S., Kumar M.N., Pindiprolu S.K.
Drug Delivery,
2016
7.
Cabral H., Miyata K., Osada K., Kataoka K.
Chemical Reviews,
2018
8.
Razuvaeva E.V., Kulebyakina A.I., Streltsov D.R., Bakirov A.V., Kamyshinsky R.A., Kuznetsov N.M., Chvalun S.N., Shtykova E.V.
Langmuir,
2018
9.
Trofimchuk E.S., Moskvina M.A., Ivanova O.A., Potseleev V.V., Demina V.A., Nikonorova N.I., Bakirov A.V., Sedush N.G., Chvalun S.N.
Mendeleev Communications,
2020
10.
Song X., Zhao Y., Wu W., Bi Y., Cai Z., Chen Q., Li Y., Hou S.
International Journal of Pharmaceutics,
2008
11.
Yadav K.S., Sawant K.K.
AAPS PharmSciTech,
2010
12.
10.1016/j.mencom.2021.07.025_b0060
Balabanyan
Biofarm. Zh.,
2013
13.
10.1016/j.mencom.2021.07.025_b0065
Pieper
Mater. Today: Proc.,
2017
14.
Madani F., Esnaashari S.S., Mujokoro B., Dorkoosh F., Khosravani M., Adabi M.
Advanced Pharmaceutical Bulletin,
2018
15.
Maeda H.
Journal of Controlled Release,
2012
16.
Gryparis E.C., Hatziapostolou M., Papadimitriou E., Avgoustakis K.
European Journal of Pharmaceutics and Biopharmaceutics,
2007
17.
Jayasuriya A.C., Darr A.J.
Journal of Biomedical Science and Engineering,
2013
18.
C. de S. L. Oliveira A.L., Araújo Júnior R.F., Gomes de Carvalho T., B. Chan A., Schomann T., Tamburini F., de Geus-Oei L., J. Cruz L.
Pharmaceutics,
2020
19.
Park T.G.
Biomaterials,
1995
20.
Ermolenko Y.V., Semyonkin A.S., Ulianova Y.V., Kovshova T.S., Maksimenko O.O., Gelperina S.E.
Russian Chemical Bulletin,
2020
21.
Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., Benita S.
International Journal of Pharmaceutics,
1989
22.
Svergun D.I., Koch M.H.
Reports on Progress in Physics,
2003
23.
Sahin A., Esendagli G., Yerlikaya F., Caban-Toktas S., Yoyen-Ermis D., Horzum U., Aktas Y., Khan M., Couvreur P., Capan Y.
Artificial Cells, Nanomedicine and Biotechnology,
2017
24.
Li X., Li R., Qian X., Ding Y., Tu Y., Guo R., Hu Y., Jiang X., Guo W., Liu B.
European Journal of Pharmaceutics and Biopharmaceutics,
2008